Mimedx Group Stock Buy Hold or Sell Recommendation
| MDXG Stock | USD 6.51 0.15 2.36% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding MiMedx Group is 'Cautious Hold'. Macroaxis provides MiMedx buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MiMedx positions. The advice algorithm takes into account all of MiMedx's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting MiMedx's buy or sell advice are summarized below:
Real Value 8.01 | Target Price 12.06 | Hype Value 6.57 | Market Value 6.51 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell MiMedx Group given historical horizon and risk tolerance towards MiMedx. When Macroaxis issues a 'buy' or 'sell' recommendation for MiMedx Group, the advice is generated through an automated system that utilizes algorithms and statistical models.
MiMedx |
Execute MiMedx Buy or Sell Advice
The MiMedx recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on MiMedx Group. Macroaxis does not own or have any residual interests in MiMedx Group or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute MiMedx's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
MiMedx Trading Alerts and Improvement Suggestions
| MiMedx Group generated a negative expected return over the last 90 days | |
| MiMedx Group is unlikely to experience financial distress in the next 2 years | |
| About 62.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: MDXG Legal Avenues |
MiMedx Returns Distribution Density
The distribution of MiMedx's historical returns is an attempt to chart the uncertainty of MiMedx's future price movements. The chart of the probability distribution of MiMedx daily returns describes the distribution of returns around its average expected value. We use MiMedx Group price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of MiMedx returns is essential to provide solid investment advice for MiMedx.
| Mean Return | -0.36 | Value At Risk | -4.29 | Potential Upside | 3.73 | Standard Deviation | 2.45 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of MiMedx historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
MiMedx Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as MiMedx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MiMedx Group backward and forwards among themselves. MiMedx's institutional investor refers to the entity that pools money to purchase MiMedx's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Charles Schwab Investment Management Inc | 2023-12-31 | 1.1 M | Royal Bank Of Canada | 2023-12-31 | 1.1 M | Northern Trust Corp | 2023-12-31 | 1.1 M | Goldman Sachs Group Inc | 2023-12-31 | 970.5 K | Prudential Financial Inc | 2023-12-31 | 938 K | Arrowstreet Capital Limited Partnership | 2023-12-31 | 922.6 K | Kanen Wealth Management Llc | 2023-09-30 | 922.5 K | Royce & Associates, Lp | 2023-12-31 | 862.5 K | Federated Hermes Inc | 2023-12-31 | 807.4 K | Essex Woodlands Health Ventures | 2023-12-31 | 28.2 M | Blackrock Inc | 2023-12-31 | 9.5 M |
MiMedx Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Other Non Cash Items | (53K) | (15.0M) | 2.1M | 4.6M | (4.8M) | (4.6M) | |
| Capital Expenditures | 10.0M | 2.2M | 3.5M | 2.7M | 2.2M | 3.6M | |
| Net Borrowings | 64.2M | (29.0M) | (38K) | (41K) | (47.2K) | (44.8K) | |
| Change To Netincome | 11.9M | 22.1M | 16.1M | 16.8M | 19.3M | 14.4M | |
| Investments | 2.7M | (4.6M) | (3.4M) | (2.7M) | (3.4M) | (3.6M) |
MiMedx Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to MiMedx or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that MiMedx's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a MiMedx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.56 | |
β | Beta against NYSE Composite | 2.36 | |
σ | Overall volatility | 2.44 | |
Ir | Information ratio | -0.18 |
MiMedx Volatility Alert
MiMedx Group exhibits very low volatility with skewness of -0.41 and kurtosis of 0.89. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure MiMedx's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact MiMedx's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.MiMedx Fundamentals Vs Peers
Comparing MiMedx's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MiMedx's direct or indirect competition across all of the common fundamentals between MiMedx and the related equities. This way, we can detect undervalued stocks with similar characteristics as MiMedx or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MiMedx's fundamental indicators could also be used in its relative valuation, which is a method of valuing MiMedx by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MiMedx to competition |
| Fundamentals | MiMedx | Peer Average |
| Return On Equity | 0.62 | -0.31 |
| Return On Asset | 0.11 | -0.14 |
| Profit Margin | 0.18 % | (1.27) % |
| Operating Margin | 0.18 % | (5.51) % |
| Current Valuation | 903.2 M | 16.62 B |
| Shares Outstanding | 146.96 M | 571.82 M |
| Shares Owned By Insiders | 3.76 % | 10.09 % |
| Shares Owned By Institutions | 61.59 % | 39.21 % |
| Number Of Shares Shorted | 5.18 M | 4.71 M |
| Price To Earning | 23.73 X | 28.72 X |
| Price To Book | 6.64 X | 9.51 X |
| Price To Sales | 2.94 X | 11.42 X |
| Revenue | 321.48 M | 9.43 B |
| Gross Profit | 219.53 M | 27.38 B |
| EBITDA | 40.52 M | 3.9 B |
| Net Income | 67.44 M | 570.98 M |
| Cash And Equivalents | 72.5 M | 2.7 B |
| Cash Per Share | 0.64 X | 5.01 X |
| Total Debt | 48.1 M | 5.32 B |
| Debt To Equity | 0.69 % | 48.70 % |
| Current Ratio | 3.53 X | 2.16 X |
| Book Value Per Share | 0.98 X | 1.93 K |
| Cash Flow From Operations | 26.77 M | 971.22 M |
| Short Ratio | 5.18 X | 4.00 X |
| Earnings Per Share | 0.43 X | 3.12 X |
| Price To Earnings To Growth | 2.97 X | 4.89 X |
| Target Price | 12.5 | |
| Number Of Employees | 895 | 18.84 K |
| Beta | 1.38 | -0.15 |
| Market Capitalization | 934.65 M | 19.03 B |
| Total Asset | 239.05 M | 29.47 B |
| Retained Earnings | (133.68 M) | 9.33 B |
| Working Capital | 118.25 M | 1.48 B |
Note: Disposition of 8896 shares by Hulse William Frank Iv of MiMedx at 6.9 subject to Rule 16b-3 [view details]
MiMedx Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as MiMedx . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About MiMedx Buy or Sell Advice
When is the right time to buy or sell MiMedx Group? Buying financial instruments such as MiMedx Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 48.1M | 48.6M | 48.1M | 25.0M | Total Assets | 187.9M | 171.4M | 239.0M | 251.0M |
Use Investing Ideas to Build Portfolios
In addition to having MiMedx in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Coal Thematic Idea Now
Coal
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Coal theme has 12 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Coal Theme or any other thematic opportunities.
| View All Next | Launch |
Check out MiMedx Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is MiMedx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4 | Earnings Share 0.43 | Revenue Per Share 2.76 | Quarterly Revenue Growth 0.167 | Return On Assets 0.113 |
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.